cytopenias after axi-cel in r/r large b-cell lymphoma: clinical implications
Published 5 years ago • 92 plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
3:31
predicting cytopenia in lymphoma patients treated with axi-cel
-
2:33
large b-cell lymphoma: relapsing post-axi-cel
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
2:00
utilizing cytokine profiles at baseline to predict cytopenia after treatment with ide-cel
-
12:13
apoptosis assay - annexinv pi
-
23:23
identifying and treating high-risk patients in 2023
-
6:28
cytoquest™ cr ctc enrichment - rbc lysis
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
10:41
trial updates in follicular lymphoma from ash 2019
-
4:48
an insight into the management of cytopenias in mf
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
0:56
cnty-101 in follicular lymphoma: a case study from the elipse-1 trial
-
1:34
recent and upcoming data on axi-cel for patients with nhl
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
1:12
the evolving role of allosct in treatment of lymphoma
-
1:36
relative dose intensity in older dlbcl patients
-
2:53
autohct in dlbcl in the car-t era